403 related articles for article (PubMed ID: 21169736)
21. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
[TBL] [Abstract][Full Text] [Related]
22. Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands.
Rao PH; Roberts D; Zhao YJ; Bell D; Harris CP; Weber RS; El-Naggar AK
Clin Cancer Res; 2008 Aug; 14(16):5181-7. PubMed ID: 18698036
[TBL] [Abstract][Full Text] [Related]
23. [Advances in genetics and pathology of salivary gland tumors].
Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Apr; 47(4):193-8. PubMed ID: 22800695
[No Abstract] [Full Text] [Related]
24. Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours.
Faur AC; Lazar E; Cornianu M
APMIS; 2014 May; 122(5):418-26. PubMed ID: 23937241
[TBL] [Abstract][Full Text] [Related]
25. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
Monteiro LS; Bento MJ; Palmeira C; Lopes C
J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
[TBL] [Abstract][Full Text] [Related]
27. [2009 update in salivary gland tumoral pathology].
Uro-Coste E
Ann Pathol; 2009 Sep; 29(4):274-85. PubMed ID: 19900633
[TBL] [Abstract][Full Text] [Related]
28. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
Foschini MP; Krausz T
Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence in situ hybridization for detection of MAML2 rearrangements in oncocytic mucoepidermoid carcinomas: utility as a diagnostic test.
García JJ; Hunt JL; Weinreb I; McHugh JB; Barnes EL; Cieply K; Dacic S; Seethala RR
Hum Pathol; 2011 Dec; 42(12):2001-9. PubMed ID: 21777943
[TBL] [Abstract][Full Text] [Related]
30. Mucoepidermoid carcinoma ex pleomorphic adenoma: nonspecific preoperative cytologic findings in six cases.
Klijanienko J; El-Naggar AK; Servois V; Rodriguez J; Validire P; Vielh P
Cancer; 1998 Aug; 84(4):231-4. PubMed ID: 9723598
[TBL] [Abstract][Full Text] [Related]
31. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
32. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior.
Tirado Y; Williams MD; Hanna EY; Kaye FJ; Batsakis JG; El-Naggar AK
Genes Chromosomes Cancer; 2007 Jul; 46(7):708-15. PubMed ID: 17437281
[TBL] [Abstract][Full Text] [Related]
33. Unique expression of MUC3, MUC5AC and cytokeratins in salivary gland carcinomas.
Lee JH; Lee JH; Kim A; Kim I; Chae YS
Pathol Int; 2005 Jul; 55(7):386-90. PubMed ID: 15982212
[TBL] [Abstract][Full Text] [Related]
34. Immunoexpression of GLUT-1 and angiogenic index in pleomorphic adenomas, adenoid cystic carcinomas, and mucoepidermoid carcinomas of the salivary glands.
de Souza LB; de Oliveira LC; Nonaka CFW; Lopes MLDS; Pinto LP; Queiroz LMG
Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2549-2556. PubMed ID: 28299426
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of Ki-67 in salivary gland carcinomas.
Larsen SR; Bjørndal K; Godballe C; Krogdahl A
J Oral Pathol Med; 2012 Sep; 41(8):598-602. PubMed ID: 22530699
[TBL] [Abstract][Full Text] [Related]
36. [Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].
Fehr A; Stenman G; Bullerdiek J; Löning T
Pathologe; 2009 Nov; 30(6):466-71. PubMed ID: 19784654
[TBL] [Abstract][Full Text] [Related]
37. Analysis of histologic follow-up and risk of malignancy for salivary gland neoplasm of uncertain malignant potential proposed by the Milan System for Reporting Salivary Gland Cytopathology.
Liu H; Ljungren C; Lin F; Zarka MA; Chen L
Cancer Cytopathol; 2018 Jul; 126(7):490-497. PubMed ID: 29669190
[TBL] [Abstract][Full Text] [Related]
38. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.
Schwarz S; Müller M; Ettl T; Stockmann P; Zenk J; Agaimy A
Int J Clin Exp Pathol; 2011 Apr; 4(4):336-48. PubMed ID: 21577319
[TBL] [Abstract][Full Text] [Related]
39. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
40. [Bcl-2 gene protein expression in salivary gland tumors].
Yáñez M; Roa I; García M; Ibacache G; Villaseca M
Rev Med Chil; 1999 Feb; 127(2):139-42. PubMed ID: 10436692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
